Biotech Co. Zymergen ‘s Rollercoaster Journey: From a Blockbuster IPO to Chapter 11

0
337

Efforts to solicit comments from Zymergen’s representatives met with silence. The company’s legal defense is currently spearheaded by Curtis S. Miller and Matthew O. Talmo of Morris Nichols Arsht & Tunnell LLP.